84
Views
32
CrossRef citations to date
0
Altmetric
Research Article

EXPRESSION OF THE MT1 MELATONIN RECEPTOR SUBTYPE IN HUMAN CORONARY ARTERIES

, , , , , , , & show all
Pages 85-91 | Published online: 28 Feb 2001

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michal Zeman, Lubos Molcan, Iveta Herichova & Monika Okuliarova. (2016) Endocrine and cardiovascular rhythms differentially adapt to chronic phase-delay shifts in rats. Chronobiology International 33:9, pages 1148-1160.
Read now
Russel J. Reiter, Dun-Xian Tan, Sergio D. Paredes & Lorena Fuentes-Broto. (2010) Beneficial effects of melatonin in cardiovascular disease. Annals of Medicine 42:4, pages 276-285.
Read now

Articles from other publishers (30)

Hande Yapislar, Ebru Haciosmanoglu, Turkan Sarioglu & Cem Ekmekcioglu. (2022) The melatonin MT2 receptor is involved in the anti-apoptotic effects of melatonin in rats with type 2 diabetes mellitus. Tissue and Cell 76, pages 101763.
Crossref
Jorge Luis Bermudez-Gonzalez, Denya Sanchez-Quintero, Leonardo Proaño-Bernal, Rafael Santana-Apreza, Marco Antonio Jimenez-Chavarria, Jose Antonio Luna-Alvarez-Amezquita, Juan Ignacio Straface, Arantza Marie Perez-Partida, Joaquin Berarducci, Javier Ivan Armenta-Moreno, Karla Joana Garza-Cruz, Nilda Espinola-Zavaleta & Erick Alexanderson-Rosas. (2022) Role of the Antioxidant Activity of Melatonin in Myocardial Ischemia-Reperfusion Injury. Antioxidants 11:4, pages 627.
Crossref
Keming Huang, Xianling Luo, Yi Zhong, Li Deng & Jian Feng. (2022) New insights into the role of melatonin in diabetic cardiomyopathy. Pharmacology Research & Perspectives 10:1.
Crossref
Haruka Sasaki, Yi Zhang, Charles W. EmalaSr.Sr. & Kentaro Mizuta. (2021) Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle . American Journal of Physiology-Lung Cellular and Molecular Physiology 321:6, pages L991-L1005.
Crossref
Lubos Molcan, Andreas Maier, Anna Zemančíková, Katharina Gelles, Jozef Török, Michal Zeman & Isabella Ellinger. (2020) Expression of Melatonin Receptor 1 in Rat Mesenteric Artery and Perivascular Adipose Tissue and Vasoactive Action of Melatonin. Cellular and Molecular Neurobiology 41:7, pages 1589-1598.
Crossref
Eva Costanzi, Carolina Simioni, Ilaria Conti, Ilaria Laface, Gabriele Varano, Cinzia Brenna & Luca M. Neri. (2020) Two neuroendocrine G protein‐coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives. Journal of Cellular Physiology 236:4, pages 2505-2518.
Crossref
Erika Cecon, Atsuro Oishi & Ralf Jockers. (2018) Melatonin receptors: molecular pharmacology and signalling in the context of system bias. British Journal of Pharmacology 175:16, pages 3263-3280.
Crossref
Jacquie Baker & Kurt Kimpinski. (2018) Role of melatonin in blood pressure regulation: An adjunct anti-hypertensive agent. Clinical and Experimental Pharmacology and Physiology 45:8, pages 755-766.
Crossref
Meredith E Kernbach, Richard J Hall, Nathan D Burkett-Cadena, Thomas R Unnasch & Lynn B Martin. (2018) Dim light at night: physiological effects and ecological consequences for infectious disease. Integrative and Comparative Biology.
Crossref
Lennart J. de Vries, Tamas Géczy & Tamas Szili-Torok. (2017) Sleep Medications Containing Melatonin can Potentially Induce Ventricular Arrhythmias in Structurally Normal Hearts: A 2-Patient Report. Journal of Cardiovascular Pharmacology 70:4, pages 267-270.
Crossref
Gaia Favero, Lorenzo Franceschetti, Barbara Buffoli, Mohammed H. Moghadasian, Russel J. Reiter, Luigi F. Rodella & Rita Rezzani. (2017) Melatonin: Protection against age-related cardiac pathology. Ageing Research Reviews 35, pages 336-349.
Crossref
Rui An, Lei Zhao, Cong Xi, Haixun Li, Guohong Shen, Haixiao Liu, Shumiao Zhang & Lijun Sun. (2015) Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism. Basic Research in Cardiology 111:1.
Crossref
Cem Ekmekcioglu. (2014) Expression and putative functions of melatonin receptors in malignant cells and tissuesExpression und mögliche Funktionen von Melatonin-Rezeptoren in humanen Karzinomzellen und im Krebsgewebe. Wiener Medizinische Wochenschrift 164:21-22, pages 472-478.
Crossref
Cem Ekmekcioglu & Theresia Thalhammer. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice 1 15 .
Hayam G. Sayyed, Rumi J. Jaumdally, Naglaa K. Idriss, Dalia A. El Sers & Andrew Blann. (2013) The Effect of Melatonin on Plasma Markers of Inflammation and on Expression of Nuclear Factor-Kappa Beta in Acetic Acid-Induced Colitis in the Rat. Digestive Diseases and Sciences 58:11, pages 3156-3164.
Crossref
Sima Samimi-Fard, Pedro Abreu-Gonzalez, Alberto Dominguez-Rodriguez & Alejandro Jimenez-Sosa. (2011) A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population. Journal of Pineal Research 51:4, pages 400-404.
Crossref
Elena Grossini, Claudio Molinari, Francesca Uberti, David A. S. G. Mary, Giovanni Vacca & Philippe P. Caimmi. (2011) Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs. Journal of Pineal Research 51:2, pages 246-257.
Crossref
Indrajit Chowdhury & Saumen Maitra. 2011. Melatonin in the Promotion of Health, Second Edition. Melatonin in the Promotion of Health, Second Edition 1 60 .
Katherine Forman, Elena Vara, Cruz García, Roman Kireev, Sara Cuesta, Darío Acuña-Castroviejo & J. A. F. Tresguerres. (2010) Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. Journal of Pineal Research 49:3, pages 312-320.
Crossref
Margarita L. Dubocovich, Philippe Delagrange, Diana N. Krause, David Sugden, Daniel P. Cardinali & James Olcese. (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors. Pharmacological Reviews 62:3, pages 343-380.
Crossref
Melanie Rüger & Frank A. J. L. Scheer. (2009) Effects of circadian disruption on the cardiometabolic system. Reviews in Endocrine and Metabolic Disorders 10:4, pages 245-260.
Crossref
Sara Carbajo-Pescador, Javier Martín-Renedo, Andrés García-Palomo, María J. Tuñón, José L. Mauriz & Javier González-Gallego. (2009) Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. Journal of Pineal Research 47:4, pages 330-338.
Crossref
Alberto Domínguez-Rodríguez, Sima Samimi-Fard, Pedro Abreu-González & Juan Carlos Kaski. (2009) Melatonina y aterosclerosis coronaria. Clínica e Investigación en Arteriosclerosis 21:5, pages 247-256.
Crossref
Paul D. Terry, Francois Villinger, George A. Bubenik & Shanti V. Sitaraman. (2009) Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research. Inflammatory Bowel Diseases 15:1, pages 134-140.
Crossref
C. Ekmekcioglu. (2006) Melatonin receptors in humans: biological role and clinical relevance. Biomedicine & Pharmacotherapy 60:3, pages 97-108.
Crossref
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Martín Garcia-Gonzalez & Russel J. Reiter. (2006) Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 97:8, pages 1162-1164.
Crossref
Sergey V. Anisimov & Natalija Popovic. (2004) Genetic Aspects of Melatonin Biology. Reviews in the Neurosciences 15:3.
Crossref
Stephen T O'Rourke, Hana Hammad, Philippe Delagrange, Elizabeth Scalbert & Paul M Vanhoutte. (2003) Melatonin inhibits nitrate tolerance in isolated coronary arteries. British Journal of Pharmacology 139:7, pages 1326-1332.
Crossref
Cem Ekmekcioglu, Theresia Thalhammer, Susanne Humpeler, Mohammad R. Mehrabi, Helmut D. Glogar, Thomas Hölzenbein, Ognjen Markovic, Valentin J. Leibetseder, Gerhard Strauss-Blasche & Wolfgang Marktl. (2003) The melatonin receptor subtype MT 2 is present in the human cardiovascular system . Journal of Pineal Research 35:1, pages 40-44.
Crossref
Egemen Savaskan. (2002) Melatonin in aging and neurodegeneration. Drug Development Research 56:3, pages 482-490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.